Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species | |
Zhang, Ying1,2; Yao, Lingling3,4,5; Tang, Chunping4,5; Jiang, Jianlan1; Ye, Yang3,4,5; Liu, Jia2 | |
刊名 | BIOMEDICAL CHROMATOGRAPHY |
2021-08-23 | |
页码 | 8 |
关键词 | gut microbiota LC-MS PPD-type ginsenosides species |
ISSN号 | 0269-3879 |
DOI | 10.1002/bmc.5219 |
通讯作者 | Jiang, Jianlan(jljiang@tju.edu.cn) ; Ye, Yang(yye@simm.ac.cn) ; Liu, Jia(jia.liu@simm.ac.cn) |
英文摘要 | Ginsenosides Rb1, Rb2, Rb3 and Rc, four major protopanaxadiol (PPD)-type ginsenosides, can be metabolized by gut microbiota. The composition of gut microbiota varies in different species. Existing publications have reported the metabolite fates of ginsenosides by gut microbiota from single species. However, their microbiota-related metabolic species differences have not been evaluated yet. In current study, in vitro anaerobic incubations of PPD-type ginsenosides with gut microbiota from humans, rabbits and rats were conducted. The metabolites of each ginsenoside were then identified by LC-MS. A total of 15 metabolites from the four ginsenosides were identified. The major metabolic pathways were stepwise removals of the C-20 and C-3 sugar moieties to obtain aglycone PPD. The results showed that the hydrolysis rate of C-20 terminal beta-D-glucopyranosyl was significantly higher than those of alpha-L-arabinopyranosyl, beta-D-xylopyranosyl and alpha-L-arabinofuranosyl in different species. The activity of beta-glucosidase, the metabolic rates of parent compounds and the formation rates of their metabolites were significantly higher in gut microbiota from rabbits than from humans and rats. Our research draws researchers' attention to the species differences of microbiota-related drug metabolism. |
资助项目 | Science and Technology Commission of Shanghai Municipality[20430780300] ; National Natural Science Foundation of China[81803610] |
WOS关键词 | HUMAN INTESTINAL MICROFLORA ; PANAX-QUINQUEFOLIUS ; GINSENG SAPONINS ; BIOTRANSFORMATION ; EXTRACT ; IDENTIFICATION ; PHARMACOLOGY ; BIOACTIVITY ; PROFILE ; GENE |
WOS研究方向 | Biochemistry & Molecular Biology ; Chemistry ; Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | WILEY |
WOS记录号 | WOS:000687349100001 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/297952] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Jiang, Jianlan; Ye, Yang; Liu, Jia |
作者单位 | 1.Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300350, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China 3.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China 5.Chinese Acad Sci, Shanghai Inst Mat Med, Nat Prod Chem Dept, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Ying,Yao, Lingling,Tang, Chunping,et al. Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species[J]. BIOMEDICAL CHROMATOGRAPHY,2021:8. |
APA | Zhang, Ying,Yao, Lingling,Tang, Chunping,Jiang, Jianlan,Ye, Yang,&Liu, Jia.(2021).Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species.BIOMEDICAL CHROMATOGRAPHY,8. |
MLA | Zhang, Ying,et al."Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species".BIOMEDICAL CHROMATOGRAPHY (2021):8. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论